F

Fresenius Medical Care AG & Co KGaA
F:FME

Watchlist Manager
Fresenius Medical Care AG & Co KGaA
F:FME
Watchlist
Price: 41.11 EUR 1.31% Market Closed
Market Cap: €12.1B

Wall St Price Targets

FME Price Targets Summary
Fresenius Medical Care AG & Co KGaA

Wall Street analysts forecast FME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FME is 44.37 EUR with a low forecast of 22.44 EUR and a high forecast of 65.19 EUR.

Lowest Forecast
Price Target
22.44 EUR
45% Downside
Average Forecast
Price Target
44.37 EUR
8% Upside
Highest Forecast
Price Target
65.19 EUR
59% Upside
Fresenius Medical Care AG & Co KGaA Competitors:
Price Targets
SIGI
Selective Insurance Group Inc
0% Downside
SMMT
Summit Therapeutics Inc
100% Upside
CNC
Concurrent Technologies PLC
13% Upside
APO
Apollo Global Management Inc
17% Upside

Revenue
Forecast

5% / Year
Past Growth
2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
5% / Year
Past Growth
2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 2%.

Gross Profit
Forecast

2% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 5%.

Operating Income
Forecast

0% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
0% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 11%.

Pre-Tax Income
Forecast

0% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
0% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 12%.

Net Income
Forecast

0% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
0% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is FME's stock price target?
Price Target
44.37 EUR

According to Wall Street analysts, the average 1-year price target for FME is 44.37 EUR with a low forecast of 22.44 EUR and a high forecast of 65.19 EUR.

What is the Revenue forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 2%.

What is the Gross Profit forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 5%.

What is the Operating Income forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 11%.

What is the Pre-Tax Income forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 12%.

What is the Net Income forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett